Nexalin Technology (NXL) Change in Receivables (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Change in Receivables of -$755.0 in Q1 2026, down 102.06% quarter-over-quarter from $36729.0 in Q4 2025, and down 290.66% on a YoY basis from $396.0 in Q1 2025.
Nexalin Technology (NXL) Change in Receivables (2021 - 2026) Analysis & Trends
Nexalin Technology's Change in Receivables history runs 6 years deep, the most recent figure standing at -$755.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 290.66% year-over-year to -$755.0; the TTM figure through Mar 2026 stood at $32571.0 (up 681.08% YoY), while the FY2025 annual figure was $33722.0, up 817.86% from the prior year.
- Change in Receivables was -$755.0 for Q1 2026 at Nexalin Technology, down from $36729.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $53540.0 in Q1 2022 to a low of -$34980.0 in Q2 2022.
- Historically, Change in Receivables has averaged $2329.2 across 5 years, with a median of -$427.5 in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables plunged 965.22% in 2024, then jumped 1071.95% in 2025.
- A 5-year view of Change in Receivables shows it stood at -$5477.0 in 2022, then plunged by 59.36% to -$8728.0 in 2023, then jumped by 135.91% to $3134.0 in 2024, then surged by 1071.95% to $36729.0 in 2025, then sank by 102.06% to -$755.0 in 2026.
- The last three Change in Receivables figures came in at -$755.0 (Q1 2026), $36729.0 (Q4 2025), and -$3403.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | -755.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -755.00 |
| Mar 31, 2026 | -755.00 |
| Dec 31, 2025 | 36,729.00 |
| Dec 31, 2025 | 36,729.00 |
| Jun 30, 2025 | -3,403.00 |
| Jun 30, 2025 | -3,403.00 |
| Mar 31, 2025 | 396.00 |
| Mar 31, 2025 | 396.00 |
| Dec 31, 2024 | 3,134.00 |
| Dec 31, 2024 | 3,134.00 |
| Sep 30, 2024 | -1,393.00 |
| Sep 30, 2024 | -1,393.00 |
| Jun 30, 2024 | 2,033.00 |
| Jun 30, 2024 | 2,033.00 |
| Mar 31, 2024 | -100.00 |
| Mar 31, 2024 | -100.00 |
| Dec 31, 2023 | -8,728.00 |
| Dec 31, 2023 | -8,728.00 |
| Sep 30, 2023 | 161.00 |
| Sep 30, 2023 | 161.00 |